To address the exploding demand for efficacious mental healthcare globally, Mobio Interactive has developed and commercialised an AI-powered digital theragnostic platform that delivers clinically validated psychotherapy programmes personalised to every patient using digital biomarkers that quantify human brain states without relying on a wearable.